$5.080
+0.010 (+0.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ABUS por análisis de gráficos similares
Alphio's ABUS stock price prediction model matches the current Arbutus Biopharma Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.03 (-1.16%). The 1-week path is $5.19 (+1.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Arbutus Biopharma Corp?
Arbutus Biopharma Corp is a good buy right now, primarily due to its recent announcement of a $230 million share buyback plan, which is expected to bolster market confidence and potentially drive the stock price higher. The current price of $5.07 is below the buyback range of $5.00 to $5.75, presenting a favorable entry point. Additionally, the stock has shown a 32.72% increase over the past year, indicating strong long-term growth potential. However, investors should be aware of the risk posed by the company's recent earnings report, which showed a loss of $0.03 per share in Q2 2026, reflecting ongoing volatility in profitability.
ABUS cerró en $5.08 el Monday, tras subir +0.20%
Arbutus Biopharma Corp (ABUS) last closed at $5.09, gaining +0.20%. These facts feed the 1-day and 1-week ABUS price prediction above.
Consenso de analistas
Arbutus Biopharma Corp (ABUS): 6 comprar, 1 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Arbutus Biopharma Corp (ABUS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ABUS, ordenadas por similitud.
Análisis de estacionalidad de ABUS
Historically the probability of a positive September return for ABUS is 100.00%. September offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ABUS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $2.44 | $2.58 | $2.77 | -49.37% |
| Oct 2026 | $2.37 | $2.65 | $2.92 | -47.85% |
| Nov 2026 | $2.25 | $2.55 | $2.93 | -49.87% |
| Dec 2026 | $2.71 | $2.82 | $3.18 | -44.58% |
En 2026, se proyecta que Arbutus Biopharma Corp (ABUS) oscile entre $2.25 y $3.18.
Previsión mensual de Arbutus Biopharma Corp para 2026
En Sep de 2026, se proyecta que Arbutus Biopharma Corp promedie $2.58, con un mínimo de $2.44 y un máximo de $2.77.
En Oct de 2026, se proyecta que Arbutus Biopharma Corp promedie $2.65, con un mínimo de $2.37 y un máximo de $2.92.
En Nov de 2026, se proyecta que Arbutus Biopharma Corp promedie $2.55, con un mínimo de $2.25 y un máximo de $2.93.
En Dec de 2026, se proyecta que Arbutus Biopharma Corp promedie $2.82, con un mínimo de $2.71 y un máximo de $3.18.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.